Mather Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.1M | Buy |
8,811
+891
| +11% | +$318K | 0.03% | 176 |
|
|
2025
Q4 | $2.59M | Buy |
7,920
+3
| +0% | +$952 | 0.03% | 171 |
|
|
2025
Q3 | $2.23M | Buy |
7,917
+468
| +6% | +$136K | 0.02% | 189 |
|
|
2025
Q2 | $2.08M | Sell |
7,449
-343
| -4% | -$97.2K | 0.02% | 187 |
|
|
2025
Q1 | $2.43M | Sell |
7,792
-462
| -6% | -$136K | 0.03% | 167 |
|
|
2024
Q4 | $2.15M | Sell |
8,254
-710
| -8% | -$211K | 0.03% | 159 |
|
|
2024
Q3 | $2.89M | Sell |
8,964
-329
| -4% | -$108K | 0.04% | 145 |
|
|
2024
Q2 | $2.64M | Sell |
9,293
-3,025
| -25% | -$889K | 0.03% | 160 |
|
|
2024
Q1 | $3.55M | Buy |
12,318
+56
| +0.5% | +$16.4K | 0.06% | 115 |
|
|
2023
Q4 | $3.53M | Buy |
12,262
+1,146
| +10% | +$312K | 0.06% | 120 |
|
|
2023
Q3 | $2.99M | Buy |
11,116
+652
| +6% | +$163K | 0.05% | 122 |
|
|
2023
Q2 | $2.32M | Buy |
10,464
+1,868
| +22% | +$433K | 0.04% | 151 |
|
|
2023
Q1 | $2.08M | Buy |
8,596
+4,485
| +109% | +$1.1M | 0.04% | 146 |
|
|
2022
Q4 | $1.08M | Sell |
4,111
-216
| -5% | -$57.9K | 0.02% | 198 |
|
|
2022
Q3 | $975K | Buy |
4,327
+230
| +6% | +$55.8K | 0.02% | 200 |
|
|
2022
Q2 | $997K | Buy |
4,097
+91
| +2% | +$22.3K | 0.02% | 185 |
|
|
2022
Q1 | $969K | Sell |
4,006
-4,031
| -50% | -$926K | 0.02% | 176 |
|
|
2021
Q4 | $1.81M | Buy |
8,037
+188
| +2% | +$39.7K | 0.04% | 101 |
|
|
2021
Q3 | $1.67M | Buy |
7,849
+2,258
| +40% | +$520K | 0.04% | 84 |
|
|
2021
Q2 | $1.36M | Buy |
5,591
+1,134
| +25% | +$279K | 0.03% | 89 |
|
|
2021
Q1 | $1.11M | Buy |
4,457
+949
| +27% | +$226K | 0.03% | 94 |
|
|
2020
Q4 | $807K | Buy |
3,508
+116
| +3% | +$26.7K | 0.03% | 102 |
|
|
2020
Q3 | $862K | Buy |
3,392
+167
| +5% | +$41.4K | 0.03% | 99 |
|
|
2020
Q2 | $761K | Buy |
3,225
+1,111
| +53% | +$253K | 0.03% | 105 |
|
|
2020
Q1 | $429K | Buy |
2,114
+437
| +26% | +$95.5K | 0.03% | 96 |
|
|
2019
Q4 | $404K | Buy |
+1,677
| New | +$370K | 0.03% | 102 |
|
|
2016
Q1 | – | Sell |
-2,548
| Closed | -$414K | – | 30 |
|
|
2015
Q4 | $414K | Hold |
2,548
| – | – | 0.1% | 28 |
|
|
2015
Q3 | $352K | Buy |
2,548
+13
| +0.5% | +$2.05K | 0.09% | 23 |
|
|
2015
Q2 | $405K | Hold |
2,535
| – | – | 0.11% | 20 |
|
|
2015
Q1 | $405K | Buy |
2,535
+12
| +0.5% | +$1.89K | 0.11% | 20 |
|
|
2014
Q4 | $402K | Buy |
2,523
+9
| +0.4% | +$1.4K | 0.12% | 20 |
|
|
2014
Q3 | $353K | Buy |
2,514
+11
| +0.4% | +$1.44K | 0.11% | 18 |
|
|
2014
Q2 | $296K | Buy |
2,503
+13
| +0.5% | +$1.5K | 0.1% | 18 |
|
|
2014
Q1 | $307K | Buy |
2,490
+12
| +0.5% | +$1.46K | 0.11% | 20 |
|
|
2013
Q4 | $283K | Buy |
+2,478
| New | +$282K | 0.11% | 24 |
|
Other funds holding AMGN
VCM
VPM
Mather Group's AMGN Position: Q1 2026 in Review
Mather Group increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $318K and bringing the position to 8,811 shares worth $3.1M. The position accounts for 0.03% of the portfolio, ranked #176.
Mather Group first reported a position in AMGN in Q4 2013 and has held it in 35 quarters since. The position peaked at $3.55M in Q1 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Mather Group held 8,811 shares of Amgen worth $3.1M as of Q1 2026.
- Mather Group bought 891 Amgen shares in Q1 2026, an estimated $318K.
- Amgen made up 0.03% of Mather Group's portfolio in Q1 2026, its #176 holding.
- Mather Group first reported a position in Amgen in Q4 2013 and has held it in 35 quarters since.
- Mather Group's Amgen position peaked at $3.55M in Q1 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.